n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Adenocarcinoma in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartolozzi, C; Boggi, U; Boraschi, P; Del Chiaro, M; Donati, F; Faggioni, L; Falaschi, F; Gigoni, R; Salemi, S | 1 |
Függer, R; Grabenwöger, F; Novacek, G; Oettl, C; Ryan, JM; Schima, W; Schober, E; Wamser, P | 1 |
Blake, M; Fischman, AJ; Hahn, PF; Kadavigere, R; Kalva, SP; Sahani, DV; Saini, S | 1 |
Fischman, AJ; Hahn, PF; Kalva, SP; Mueller, P; Ryan, D; Sahani, DV; Saini, S | 1 |
Eser, C; Eser, G; Karabacakoglu, A; Karakose, S; Kayacetin, E | 1 |
Bocchi, C; Corradi, D; De Filippo, M; Quartieri, L; Zompatori, M | 1 |
Gehl, HB; Günther, RW; Hauptmann, S; Klever, P | 1 |
Bohndorf, K; Gehl, HB; Günther, RW; Hauptmann, S; Klever, P; Lodemann, KP; Matern, S; Schumpelick, V; Urhahn, R | 1 |
Wang, C | 1 |
2 trial(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Adenocarcinoma
Article | Year |
---|---|
[Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings].
Topics: Adenocarcinoma; Adenoma, Islet Cell; Chronic Disease; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 1993 |
Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
Topics: Adenocarcinoma; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Neoplasms; Pyridoxal Phosphate | 1993 |
7 other study(ies) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Adenocarcinoma
Article | Year |
---|---|
Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Pyridoxal Phosphate; Secretin; Tomography, X-Ray Computed | 2009 |
Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, X-Ray Computed | 2002 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 2006 |
Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.
Topics: Adenocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2007 |
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Body Water; Brain; Carcinoid Tumor; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Dose-Response Relationship, Drug; Edetic Acid; Female; Humans; Image Enhancement; Infusions, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pyridoxal Phosphate; Safety; Sensitivity and Specificity; Time Factors | 1998 |